Digital communication in health promotion in handling tuberculosis sputum

Main Article Content

Linda Augustien Makalew Elne Vieke Rambi Muhammad Ali Makaminan Risman S Duka Tumartony Hiola


The Covid-19 pandemic that has caught the attention of not only Indonesia but the rest of the world. The 3M movement, namely using masks, washing hands and keeping a distance to minimize the transmission of tuberculosis, is very useful for the eradication of TB tuberculosis. However, this is a challenge in itself for microscopic officers at the Microscopic Reference Center (MRC) in education and handling of sputum for tuberculosis patients who are currently being treated. The purpose of this study was to test VisKomLAM 1, 2, 3 and 4 in bridging communication between officers in sputum management education for tuberculosis sufferers at each examination during the Covid-19 pandemic. The research locations took MRC Tuminting, Wawonasa and Tikala Baru in Manado City and MRC Telaga in Gorontalo District. Analysis with paired t test showed a significance below 5%, which means that VisKomLAM 1, 2, 3 and 4 can bridge education from officers to tuberculosis sufferers in the Covid-19 pandemic era. It is recommended that health workers always strive to promote tuberculosis health in achieving tuberculosis elimination by 2050.


Download data is not yet available.

Article Details

How to Cite
Makalew, L., Rambi, E., Makaminan, M., Duka, R., & Hiola, T. (2021). Digital communication in health promotion in handling tuberculosis sputum. Jurnal Teknologi Laboratorium, 10(1), 46-52.


1. Mwamba C, Kerkhoff AD, Kagujje M, Lungu P, Muyoyeta M, Sharma A. Diagnosed with TB in the era of COVID-19: patient perspectives in Zambia. Public Heal Action. 2020;10(4):141-146. doi:10.5588/pha.20.0053.
2. Behera D. TB control in India in the COVID era. Indian J Tuberc. 2021;68(1):128-133. doi:10.1016/j.ijtb.2020.08.019.
3. ALkharashi NA. Estimation of vitamin D deficiency prevalence among Saudi children in Armed Forces Hospital and Riyadh Care Hospital in Riyadh, Kingdom of Saudi Arabia and its relation to type 1 diabetes mellitus. Saudi Med J. 2019;40(12):1290-1293. doi:10.15537/smj.2019.12.24643.
4. Kementerian Kesehatan RI. Profil Kesehatan Indonesia Tahun 2019.; 2020.
5. World Health Organization 2020. Global Tuberculosis Report 2020.; 2021.
6. Malik AA, Safdar N, Chandir S, et al. Tuberculosis control and care in the era of COVID-19. Health Policy Plan. 2020;35(8):1130-1132. doi:10.1093/heapol/czaa109.
7. Sayo AR, Balinas EGM, Verona JA, et al. COVID-19 screening on a tuberculosis ward in Manila, the Philippines. J Clin Tuberc Other Mycobact Dis. 2020;20:100167. doi:10.1016/j.jctube.2020.100167.
8. Chen H, Zhang K. Early View Insight into impact of COVID-19 epidemic on tuberculosis burden in China. Published online 2020.
9. Makalew LA, Kuntoro, Otok BW, Soenarnatalina M, Layuk S. Modeling the Number of Cases of Tuberculosis Sensitive Drugs (TBSD) in East Java using Geographically Weighted Poisson Regression ( GWPR ). Indian J Public Heal Res Dev. 2019;10(6):398. doi:10.5958/0976-5506.2019.01305.6
10. Daw MA, Zgheel FA, El-Bouzedi A, Ahmed MO. Spatiotemporal Distribution of Tuberculosis and COVID-19 During the COVID-19 Pandemic in Libya. Disaster Med Public Health Prep. Published online November 19, 2020:1-3. doi:10.1017/dmp.2020.458.
11. Winda Pitaloka NS. Penerapan Empat Pilar Program Pencegahan dan Pengendalian Infeksi Tuberkulosis Paru. Higeia J Public Heal Res Dev. 2018;1(3):84-94.
12. Dookie N, Padayatchi N, Naidoo K. Tuberculosis Elimination in the Era of Coronavirus Disease 2019 (COVID-19): A Moving Target. Clin Infect Dis. 2020;2019(Xx):1-2. doi:10.1093/cid/ciaa1400.
13. McQuaid CF, Vassall A, Cohen T, Fiekert K, COVID/TB Modelling Working Group, White RG. The impact of COVID-19 on TB: a review of the data. Int J Tuberc Lung Dis. 2021;25(6):436-446. doi:10.5588/ijtld.21.0148.
14. Reiss MJ. Science Education in the Light of COVID-19. Sci Educ. 2020;29(4):1079-1092. doi:10.1007/s11191-020-00143-5.
15. Nyang’wa BT, LaHood AN, Mitnick CD, Guglielmetti L. TB research requires strong protections, innovation, and increased funding in response to COVID-19. Trials. 2021;22(1):371. doi:10.1186/s13063-021-05331-4.
16. Nhari LG, Dzobo M, Chitungo I, Denhere K, Musuka G, Dzinamarira T. Implementing effective TB prevention and treatment programmes in the COVID-19 era in Zimbabwe. A call for innovative differentiated service delivery models. Public Heal Pract. 2020;1(October):100058. doi:10.1016/j.puhip.2020.100058.
17. Netherton A, Chang M. From evidence into action - Using the planning system to promote healthy weight environments. Public Heal Pract. 2020;1(April):100007. doi:10.1016/j.puhip.2020.100007.
18. Makalew LA, Kuntoro, Otok BW, Soenarnatalina M. Spatio of Lungs Tuberculosis ( Tb Lungs ) in East Java Using Geographically Weighted Poisson Regression (GWPR). Indian J Public Heal Res Dev. 2019;10(8):1830. doi:10.5958/0976-5506.2019.02115.6.
19. Linda Augustien Makalew, Kuntoro, Bambang Widjanarko Otok, Soenarnatalina M. SL. Modeling the Number of Cases of Tuberculosis Sensitive Drugs (TBSD) in East Java using Geographically Weighted Poisson Regression (GWPR). Indian J Public Heal Res Dev. 2019;10(6):416-421.
20. Burzynski J, Macaraig M, Nilsen D, Schluger NW. Transforming essential services for tuberculosis during the COVID-19 pandemic: lessons from New York City. Int J Tuberc Lung Dis. 2020;24(7):735-736. doi:10.5588/ijtld.20.0283.
21. Cai Y, Zhao S, Niu Y, et al. Modelling the effects of the contaminated environments on tuberculosis in Jiangsu, China. J Theor Biol. 2021;508:110453. doi:10.1016/j.jtbi.2020.110453.
22. Arcêncio et al. Multidrug-resistant tuberculosis from the health providers ’ perspective : strategies for compliance and equity in seeking the care in COVID-19 era. Res Sq. Published online 2020:1-18. doi:10.21203/
23. Al Raimi AM, Chong CM, Tang LY, Chua YP, Al Ajeel LY. Using mHealth Apps in Health Education of Schoolchildren with Chronic Disease During COVID-19 Pandemic Era. In: Studies in Systems, Decision and Control. Vol 348. ; 2021:305-317. doi:10.1007/978-3-030-67716-9_19.